Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salvianolate for stable coronary heart disease with preserved FFR and microvascular dysfunction
ChiCTR1800018772Phase 4Recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronary arteriosclerosis comparing Salvianolate group with Placebo group (2 arms). Primary endpoint: Index of microcirculatory resistance. Started Jul 2019; status: recruiting.
02
Drugs
salvianolate
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR1800018772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018772.